Caroline E. Rutten
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Immune reconstitution and infections with ATG versus post-transplant cyclophosphamide as GvHD prophylaxis after nonmyeloablative matched unrelated donor hematopoietic stem cell transplantation.
Journal: Frontiers in immunology
Published: November 04, 2025
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study.
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study.
Journal: The Journal of infectious diseases
Published: April 28, 2025
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Journal: Haematologica
Published: December 06, 2024
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.
Journal: European journal of haematology
Published: August 29, 2024
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study.
Journal: American journal of hematology
Published: March 13, 2024
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.
Journal: Blood
Published: October 11, 2023
Fusariosis in patients with hematological malignancies: Two case reports.
Journal: Medical mycology case reports
Published: June 07, 2023
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning.
Journal: British journal of haematology
Published: April 15, 2023
Last Updated: 09/26/2026